Factors affecting breast cancer patients' need for genetic risk information: From information insufficiency to information need.

BRCA1/2 breast cancer genetic information need genetic risk information genetic uncertainty interest in genetic information whole genome sequencing

Journal

Journal of genetic counseling
ISSN: 1573-3599
Titre abrégé: J Genet Couns
Pays: United States
ID NLM: 9206865

Informations de publication

Date de publication:
06 2019
Historique:
received: 14 02 2018
accepted: 04 12 2018
pubmed: 25 1 2019
medline: 9 6 2020
entrez: 25 1 2019
Statut: ppublish

Résumé

Information-seeking models typically focus on information-seeking behaviors based on individuals' interest in information, because their current level is perceived to be insufficient. In the context of genetic risk information (GRI), however, information insufficiency is difficult to measure and thus can limit understanding of information behavior in the context of GRI. We propose that an individual's need for information might be a more direct and conceptually clearer alternative to predicting their information-seeking behavior. To test this hypothesis, this study investigates the extent to which previously identified factors affecting interest in GRI are also predictors of need for GRI among women diagnosed with breast cancer at the age of 40 or younger (N = 1,069). As hypothesized, there was a positive association between interest in and need for GRI. Furthermore, hypothesized factors of numeracy, information orientation, and genetic knowledge were significant predictors of increased interest in and need for GRI. In contrast, hypothesized factors of genetic worry and genetic causal belief predicted increased interest in GRI only, while genetic self-efficacy predicted increased need for GRI only. As hypothesized, BRCA status significantly moderated associations between informational norm and both interest in and need for GRI. Collectively, the findings support inclusion of need for GRI in theoretical information-seeking models in the context of genomic risk.

Identifiants

pubmed: 30675956
doi: 10.1002/jgc4.1087
pmc: PMC6548596
mid: NIHMS1001245
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

543-557

Subventions

Organisme : NCI NIH HHS
ID : R01 CA168608
Pays : United States

Informations de copyright

© 2019 National Society of Genetic Counselors.

Références

Environ Res. 1999 Feb;80(2 Pt 2):S230-S245
pubmed: 10092438
Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):326-8
pubmed: 10207636
Br J Cancer. 2001 Jan 5;84(1):48-51
pubmed: 11139312
Psychooncology. 1995 Oct;4(3):197-202
pubmed: 11655006
Soc Sci Med. 2003 Mar;56(5):1099-109
pubmed: 12593881
J Med Internet Res. 2003 Jul-Sep;5(3):e21
pubmed: 14517112
Health Commun. 2004;16(1):29-45
pubmed: 14979850
Crit Rev Oncol Hematol. 2004 Jul;51(1):69-80
pubmed: 15207255
J Health Commun. 2004 Sep-Oct;9(5):443-60; discussion 81-4
pubmed: 15513791
Br J Cancer. 2005 May 9;92(9):1671-8
pubmed: 15841073
Am J Prev Med. 2005 Nov;29(4):375-6
pubmed: 16242604
J Health Commun. 2006;11 Suppl 1:157-72
pubmed: 16641081
J Clin Oncol. 2006 Aug 1;24(22):3672-7
pubmed: 16877736
Am J Med Genet C Semin Med Genet. 2006 Nov 15;142C(4):251-9
pubmed: 17024668
J Health Commun. 2006 Dec;11(8):717-36
pubmed: 17190779
Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):249-55
pubmed: 17267389
Ann Behav Med. 2007 Feb;33(1):1-10
pubmed: 17291165
Health Qual Life Outcomes. 2007 Mar 13;5:15
pubmed: 17352831
Med Decis Making. 2007 Sep-Oct;27(5):672-80
pubmed: 17641137
J Genet Couns. 2007 Dec;16(6):713-28
pubmed: 17934802
Genet Med. 2007 Nov;9(11):727-38
pubmed: 18007141
Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):1872-9
pubmed: 18708374
J Behav Med. 2009 Apr;32(2):197-208
pubmed: 18807164
Psychooncology. 2009 Feb;18(2):209-15
pubmed: 19061202
Health Psychol. 2009 May;28(3):307-16
pubmed: 19450036
Behav Res Methods. 2009 Aug;41(3):924-36
pubmed: 19587209
Genet Med. 2009 Aug;11(8):582-7
pubmed: 19606049
J Cancer Educ. 2009;24(4):351-6
pubmed: 19838898
Health Commun. 2010 Jun;25(4):345-56
pubmed: 20512716
Public Health Genomics. 2011;14(4-5):307-16
pubmed: 20829577
Genet Med. 2011 Apr;13(4):273-7
pubmed: 20921892
PLoS One. 2010 Oct 19;5(10):e13473
pubmed: 20976053
Public Health Genomics. 2011;14(3):178-89
pubmed: 21464556
Risk Anal. 2011 Nov;31(11):1789-99
pubmed: 21535066
Public Health Genomics. 2012;15(2):57-72
pubmed: 21921576
Psychol Health. 2006;21(2):211-30
pubmed: 21985118
J Genet Couns. 2012 Aug;21(4):510-26
pubmed: 21993709
Clin Genet. 2012 Nov;82(5):408-15
pubmed: 22694298
Psychooncology. 2013 Apr;22(4):902-10
pubmed: 22740372
Psychooncology. 2013 May;22(5):1167-76
pubmed: 22777929
J Genet Couns. 2013 Feb;22(1):118-24
pubmed: 22914993
Psychol Health. 2013;28(4):434-49
pubmed: 23121110
Health Commun. 2014;29(7):656-68
pubmed: 24093914
J Hum Nutr Diet. 2014 Oct;27(5):479-88
pubmed: 24236642
Clin Genet. 2014 Sep;86(3):229-37
pubmed: 24304220
J Health Commun. 2014 Apr;19(4):511-27
pubmed: 24433251
Clin Genet. 2015 May;87(5):473-7
pubmed: 24735105
Health Psychol. 2015 May;34(5):473-6
pubmed: 25133845
Genet Med. 2015 Aug;17(8):630-8
pubmed: 25503501
Breast Cancer Res. 2014 Sep 19;16(5):442
pubmed: 25510853
Genet Med. 2016 Jan;18(1):65-72
pubmed: 25812042
J Behav Med. 2015 Oct;38(5):727-39
pubmed: 25820809
Eur J Hum Genet. 2016 Jan;24(1):14-20
pubmed: 26036856
Ann Oncol. 2015 Oct;26(10):2057-65
pubmed: 26153499
Hum Mutat. 2016 Apr;37(4):331-6
pubmed: 26777316
Health Commun. 2016 Dec;31(12):1495-505
pubmed: 27092867
J Health Commun. 2016;21(sup2):6-15
pubmed: 27661291
Transl Behav Med. 2018 Jan 29;8(1):71-79
pubmed: 29385583
J Genet Couns. 2018 Sep;27(5):1111-1129
pubmed: 29460110
BMJ. 1996 Sep 21;313(7059):724-6
pubmed: 8819442
J Pers Soc Psychol. 1997 Mar;72(3):485-91
pubmed: 9120779
J Assoc Nurses AIDS Care. 1998 Jan-Feb;9(1):66-77
pubmed: 9436169

Auteurs

Soo Jung Hong (SJ)

Department of Communications and New Media, National University of Singapore, Singapore.

Barbara Biesecker (B)

RTI International, Washington, District of Columbia.

Jennifer Ivanovich (J)

Indiana University School of Medicine, Indianapolis, Indiana.

Melody Goodman (M)

NYU College of Global Public Health, New York, New York.

Kimberly A Kaphingst (KA)

Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Department of Communication, University of Utah, Salt Lake City, Utah.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH